January 31, 2017

Decisions by President Donald Trump’s top U.S. Supreme Court contenders, all federal appeals court judges, suggest they don’t have an “investor friendly” perspective on the use of private remedies.

Based on Trump’s campaign comments, one would expect him to select judges who take a narrow view of federal regulatory schemes, including the antifraud provisions of the federal securities laws, Washington attorney Daniel Sommers of Cohen Milstein Sellers & Toll PLLC told Bloomberg BNA.

The full article can be viewed here.